These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28802854)

  • 1. Use of axenic media to determine antibiotic efficacy against coxiella burnetii.
    Clay KA; Hartley MG; Russell P; Norville IH
    Int J Antimicrob Agents; 2018 May; 51(5):806-808. PubMed ID: 28802854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media.
    Smith CB; Evavold C; Kersh GJ
    Sci Rep; 2019 Dec; 9(1):18132. PubMed ID: 31792307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rifapentine and other rifamycins against
    Miller HK; Kersh GJ
    Microbiol Spectr; 2024 Jul; 12(7):e0103424. PubMed ID: 38864598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
    Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D
    Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid A Has Significance for Optimal Growth of
    Wang T; Yu Y; Liang X; Luo S; He Z; Sun Z; Jiang Y; Omsland A; Zhou P; Song L
    Front Cell Infect Microbiol; 2018; 8():192. PubMed ID: 29938202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using
    Clay KA; Hartley MG; Armstrong S; Bewley KR; Godwin K; Rayner E; Vipond J; Bailey M; Atkins TP; Norville IH
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0067321. PubMed ID: 34370577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.
    Rolain JM; Lambert F; Raoult D
    Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR.
    Boulos A; Rolain JM; Maurin M; Raoult D
    Int J Antimicrob Agents; 2004 Feb; 23(2):169-74. PubMed ID: 15013043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii.
    Andoh M; Naganawa T; Yamaguchi T; Fukushi H; Hirai K
    Microbiol Immunol; 2004; 48(9):661-4. PubMed ID: 15383702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori.
    Weseler A; Geiss HK; Saller R; Reichling J
    Pharmazie; 2005 Jul; 60(7):498-502. PubMed ID: 16076074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.
    Rolain JM; Boulos A; Mallet MN; Raoult D
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2673-6. PubMed ID: 15980335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
    Brennan RE; Samuel JE
    J Clin Microbiol; 2003 May; 41(5):1869-74. PubMed ID: 12734219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 17. Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae.
    Kays MB; Graff MA
    Ann Pharmacother; 2002 Mar; 36(3):416-22. PubMed ID: 11895052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media.
    Nakashima H; Takahashi H; Kameko M; Saito H
    J Infect Chemother; 2012 Dec; 18(6):970-2. PubMed ID: 22576751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of intracellular Coxiella burnetii to antimicrobial peptides in mouse fibroblast cells.
    Unsworth NB; Dawson RM; Wade JD; Liu CQ
    Protein Pept Lett; 2014; 21(2):115-23. PubMed ID: 24364858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.
    Peyrusson F; Whelan AO; Hartley MG; Norville IH; Harding SV; Van Bambeke F
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0106121. PubMed ID: 34543094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.